Introduction
============

Hydrogen sulfide (H~2~S), a well-known toxic gas characterized by its "rotten-egg" smell, has attracted substantial interest for its non-toxic effects in mammals. H~2~S was considered as an important gasotransmitter since [@B1]) discovered the enzymatic reaction process of H~2~S generation in the brain tissues along with its biological activity at a physiological concentration. Since then, the gasotransmitter H~2~S has been found to be involved physiologically and pathologically in the neuroregulation ([@B37]), vasodilatation ([@B16]), endocrinologic regulation ([@B19]), and inflammation ([@B11]), etc.

Recently, strong evidence has shown the presence of H~2~S and its endogenous synthesis pathway in the mammalian retina. This review presents the production of endogenous H~2~S and the evidence of its role in the retinal physiology and different retinal diseases including the retinal degenerative and vascular diseases, and the underlying mechanism (**Figure [1](#F1){ref-type="fig"}**).
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H~2~S Generation in the Retinal Tissues
=======================================

So far, four enzymatic pathways that regulate endogenous H~2~S production have been revealed: cystathionine-β-synthase (CBS), cystathionine-γ-lyase (CSE) ([@B47]; [@B1]), cysteine aminotransferase/3-mercaptopyruvate sulfurtransferase (CAT/3MST) ([@B18]) and [D]{.smallcaps}-amino acid oxidase (DAO)/3MST ([@B44]). However, only the first three endogenous H~2~S synthesis pathways have been reported to be involved in the retinal tissue, and there is no report of DAO/3MST pathways present in retinal tissue. The results of the distribution of the endogenous H~2~S synthesis and regulation in retinal tissue are controversial due to the different species and methods used in the study. [@B39] found the expression and activity of CBS and CSE in the retinal tissue of salamander and those of CSE in the retinal tissue of mice. [@B29] detected the expression of endogenous H~2~S producing enzymes in each layer of the retina in mice by immunohistochemistry. The result showed that 3MST and CAT were expressed in the inner plexiform layer, outer plexiform layer, inner nuclear layer, outer nuclear layer, and outer segments of photoreceptors of the retina, with the absence of CBS and CSE, which suggests that H~2~S generation might be catalyzed almost by the CAT/3MST pathway in the mouse retina ([@B29]). [@B13] further confirmed CBS, CSE, and 3MST protein expression in mouse retinal tissue by Western blot and immunohistochemistry. [@B23] used inhibitors of H~2~S-producing enzymes to study the endogenous H~2~S synthesis pathway in the bovine retina and the results showed that the use of CBS inhibitor or the use of CSE inhibitor, or the combined application of CBS and CSE inhibitors could not completely block the endogenous H~2~S generation in bovine retina, which indicated that perhaps other enzymes apart from CSE and CBE might contribute to H~2~S generation in bovine retina.

Effect of H~2~S on Retinal Physiology
=====================================

In the central nervous system (CNS), H~2~S has been reported to regulate synaptic activities as a neurotransmitter ([@B21]). However, [@B40] found that H~2~S acted as a mediator of ischemic injury on neurons and the inhibition of endogenous H~2~S production would be a potential neuroprotective strategy for stroke. Ion channels and transporters were found to be involved in the regulatory effects of H~2~S on CNS ([@B49]; [@B20]). We have few studies of the physiologic effects of H~2~S in the retina, but the presence of H~2~S and its endogenous synthesis pathway in the retina as well as the fact that deficiency of CBS may lead to retinal degeneration and detachment ([@B22]) both indicate that H~2~S plays an important role in the eye as a gaseous neuromodulator.

Effect of H~2~S on Ion Channels in the Retina
---------------------------------------------

Potassium channels including ATP-sensitive potassium channel (K~ATP~) are important to the physiologic role of H~2~S ([@B55]; [@B12]). Given the well-known regulatory effect of potassium channels in the retina ([@B8]), it is reasonable to hypothesize that H~2~S modulates retinal function by acting on the potassium channel. Njie-Mbye et al. found that glibenclamide, a K~ATP~ channel inhibitor, inhibited the H~2~S donor NaHS-induced cyclic adenosine monophosphate (cAMP) formation in rat retinal pigment epithelial (RPE) cells, suggesting that K~ATP~-channel might be involved in the effect of H~2~S on the cAMP-related RPE cell proliferation, apoptosis, and phagocytosis ([@B31]). NaHS was found to have a prominent relaxation effect on the retina arteries by acting on the voltage-dependent potassium channel (K~v~) and inwardly rectifying potassium channel (K~ir~) ([@B48]), indicating that H~2~S may play an important role in regulating the retina vascular system.

The calcium transport system exists in retinal Müller cells as well as RPE ([@B5]; [@B53]), and the change in these channels may contribute to the retinal degenerative diseases ([@B53]). [@B29] found that intracellular Ca^2+^ inhibited CAT/3MST-derived H~2~S production in retinal lysates and in turn H~2~S blocked high K^+^-induced Ca^2+^ influx via activating V-ATPase in the outer nuclear layer (ONL) and outer plexiform layer (OPL). The counteraction between the H~2~S and intracellular Ca^2+^ in the retina mediated the protective effect of H~2~S on the retinal photoreceptor apoptosis caused by excessive light ([@B29]).

Besides K^+^ and Ca^2+^ channels, other ion channels such as sodium and chloride channels are believed to have an important effect on various physiologic processes in the retina ([@B54]; [@B46]). However, whether H~2~S acts on the sodium and chloride channels has not been clear yet. Therefore, further studies need to be done to explore the possible relationship between retina-derived H~2~S and the ion channels.

Regulation of Neurotransmission by H~2~S in the Retina
------------------------------------------------------

Glutamate is an important neurotransmitter and plays a key role in the fast excitatory synaptic transmission in the CNS. Therefore, glutamate has been reported to be implicated in the physiologic processes such as neuronal development and synaptic plasticity and pathophysiologic processes such as excitotoxicity ([@B43]). \[^3^H\][D]{.smallcaps}-aspartate is a substitute for glutamate in neurotransmitter release assay. [@B32] found that both NaHS and Na~2~S donors inhibited high K^+^-evoked \[^3^H\][D]{.smallcaps}-aspartate release from isolated bovine and porcine retinae. Although the mechanisms were unclear, but it is supposed that there might be an involvement of glutamate aspartate transporter which lowers the extracellular glutamate level to protect the neurons against excitotoxic damage. One study suggested that a derivative of latanoprost acid (ACS67), which can release H~2~S, had a remarkable effect on increasing glutathione (GSH) and cyclic guanosine monophosphate (cGMP) levels in the aqueous humor ([@B38]). In the retina, the glutamate aspartate transporter is located in Müller cells and maintains the level of GSH with the toxic effects of glutamate ([@B28]). Therefore, this transporter might be a target of H~2~S to regulate neurotransmission in the retina. Future studies of the exact mechanisms are needed.

Effect of H~2~S on Retinal Pathology
====================================

Retinal diseases including retinal degenerative diseases and vascular diseases have become the leading causes of blindness reported by the World Health Organization ([@B36]). Their irreversible damage to vision and refractory characteristics make them a hot topic for ophthalmologists all over the world. Here, we discuss the effects of H~2~S on retinal degenerative diseases and vascular diseases.

H~2~S and Retinal Degenerative Diseases
---------------------------------------

Retinal degenerative diseases, commonly including retinitis pigmentosa (RP), age-related macular degeneration (AMD), and glaucomatous retinal neuropathy, share the main pathological basis of abnormal structure and function of retinal neurons at all levels, which results in an irreversible damage to visual acuity ([@B9]).

Progressive degeneration of the photoreceptor cells in the retina contributes to the severe visual injury of RP and AMD ([@B6]). The photoreceptor cell apoptosis is a key pathologic basis of human retinal degeneration and light-induced retinal degeneration models ([@B51]; [@B41]). In one study, NaHS administration suppressed the light-induced photoreceptor degeneration in association with decreasing photoreceptor cell apoptosis and DNA damage in the retinal ONL in a mice retinal degeneration model caused by excessive light exposure. Simultaneously, NaHS prevented high K^+^-evoked Ca^2+^ influx in mice retinal ONL and OPL ([@B29]), suggesting that restoring Ca^2+^ homeostasis might be involved in the protective effect of H~2~S on the photoreceptor cell apoptosis. The above findings indicate that H~2~S might act as a neuroprotector to prevent from retinal degeneration. On the other hand, abnormal function of RPE cells is an important pathological process of RP and AMD ([@B10]; [@B25]). H~2~S donor NaHS and endogenous H~2~S were found to dose-dependently increase cAMP concentrations in rat RPE cells ([@B30]), while the increase in intracellular cAMP level resulted in the downregulation of phagocytic activity of RPE cells, which would lead to the progression of RP and AMD ([@B14]; [@B24]). The above facts suggest that H~2~S might aggravate the process of RP and AMD. Collectively, whether H~2~S has a protective or deleterious effect on RP and AMD needs further research.

Although glaucoma is not usually described as a retinal disease, glaucomatous retinal neuropathy is the leading cause of vision impairment in glaucoma ([@B26]). Recently, H~2~S levels and expression of its endogenous enzymes CBS, CSE, and 3MST in retinal tissues were significantly decreased along with the loss of retinal ganglion cells (RGCs) in a chronic ocular-hypertension rat model. While the treatment with NaHS could improve the survival of RGCs without impacting on the intraocular pressure ([@B17]). However, [@B38] found that H~2~S-releasing agent ACS67 reduced the intraocular pressure in carbomer-induced glaucoma in rabbits and increased the GSH and cGMP content in aqueous humor. The above interesting results give a better understanding of the pathogenesis of glaucomatous retinal neuropathy and provide a potential therapeutic target for glaucoma.

H~2~S and Retinal Vascular Diseases
-----------------------------------

Retinal vascular diseases are defined as diseases first caused by a retinal vascular abnormality, which leads to injured retinal neurons or vision. The diseases mainly include retinal artery occlusion (RAO), retinal vein occlusion (RVO), and diabetic retinopathy (DR).

In retinal vascular occlusion, including RAO and RVO, ischemia/reperfusion (I/R) injury plays a significant role in the pathologic process ([@B3]). It causes RGCs death by inducing apoptosis and necrosis ([@B15]). Intravitreal injection of the H~2~S donor ACS67 could prevent the retinal injury caused by elevated intraocular pressure-induced retina I/R in an *in vivo* experiment. Furthermore, *in vitro* study showed that ACS67 suppressed H~2~O~2~-induced RGC-5 cell apoptosis and improved RGC-5 cell viability via increasing the GSH level and decreasing reactive oxygen species level ([@B33]). [@B4] found that inhaled H~2~S preconditioning attenuated RGC death after retina I/R injury. NF-κB, ERK/MAPK, and JNK/MAPK pathways were involved in the anti-apoptotic mechanisms for H~2~S preconditioning ([@B4]). Additionally, H~2~S could relax retinal arteries by targeting on the potassium channel ([@B48]), which might be involved in the protective effect of H~2~S on the retinal vascular diseases.

DR, due to diabetes, is a globally increasingly important retinal disease ([@B52]). High glucose-induced retinal microvasculopathy is one of the important causes of reduced visual acuity and acquired blindness. The injured pericytes and capillary blockage due to a high glucose environment, which further leads to generation of vascular endothelial growth factor (VEGF), are the most critically early pathological changes during DR ([@B27]). The process further leads to the breakdown of the blood--retinal barrier, leakage of retinal capillaries, macular edema, and neovascularization. In streptozotocin-induced diabetic rats, retina H~2~S level and CSE and 3MST mRNA were decreased. The treatment of NaHS could reduce blood--retinal barrier permeability and acellular capillaries formation in the retina along with the reduced vitreous content of VEGF and its signaling pathway ([@B45]), suggesting that retina-derived H~2~S might protect against high glucose-induced retinal microvasculopathy. However, in another study, H~2~S was found to play different roles in the development of retinal neovascularization in diabetic patients with proliferative DR (PDR). [@B42] revealed that H~2~S level was increased in both the plasma and the vitreous body of diabetic patients with PDR when compared with that in healthy people and diabetic patients without PDR. In accordance with the increase in H~2~S level, VEGF levels in the vitreous body from diabetic patients with PDR were also significantly elevated. The above clinical data suggest that H~2~S might act as a pro-angiogenesis factor to promote the progression of PDR ([@B42]), which is similar to the role of H~2~S in the development of angiogenesis in cardiovascular diseases ([@B7]; [@B35]; [@B50]). Recently, retina neurodegeneration was found to occur ahead of vascular injury during DR ([@B2]; [@B34]). [@B45] found that NaHS improved retinal neuronal dysfunction in streptozotocin-treated rats representing the facts that NaHS enhanced b-wave amplitudes and oscillatory potentials. The underlying mechanisms responsible for the neuroprotective effect of H~2~S in retina included suppressing oxidative stress, protecting mitochondrial function, and inhibiting inflammation. Taken together, H~2~S plays a complex role in the pathogenesis of DR. Further studies are needed to discover the effect and mechanisms for H~2~S in DR, which might hopefully deepen the understanding of the DR pathophysiology and help to find new treatments for this disease.

Conclusion
==========

Since H~2~S and its endogenous synthesis pathway were found in mammalian retina, studies about the effect of H~2~S on retina physiology and pathology have become a hot topic for ophthalmologists (**Figure [1](#F1){ref-type="fig"}**). In the past years, H~2~S was proved as a neuromodulator in the eye with important effects in some retinal diseases. However, the role of H~2~S in lots of retinal diseases still needs to be revealed and in-depth studies of the underlying mechanisms are bound to be necessary. As we know, unlike CNS or cardiovascular system, the unique characteristics of retina is the direct connection to the vitreous body, which is a perfect match to gaseous treatment that has been widely used in the research of many retina diseases like retinal detachment and macular membrane. Therefore, the H~2~S-related therapy has a bright future but still requires further studies.
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